v3.25.3
Stockholders' Equity - Schedule of Stockholders' Equity (Details) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance of shares outstanding, beginning of period (in shares)     150,794       150,794  
Balance, beginning of period $ 1,051,351,000 $ 906,035,000 $ 957,145,000 $ 915,809,000 $ 931,210,000 $ 947,740,000 $ 957,145,000 $ 947,740,000
Non-cash share-based compensation 3,765,000 3,481,000 2,463,000 2,781,000 2,887,000 1,409,000    
Purchase and retirement of common stock   (29,049,000) (42,223,000) (28,578,000) (39,203,000) (33,222,000)    
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding 0 86,000 (1,128,000) 80,000 91,000 (773,000)    
Change in noncontrolling interests 0              
Equitable adjustments to stock-based awards 1,000 8,000 (2,000) (3,000) 19,000 21,000    
Net income (loss) 34,379,000 97,426,000 (19,553,000) 85,327,000 128,351,000 (10,848,000) 112,252,000 202,830,000
Foreign currency translation adjustment, net of tax of $0 $ 28,619,000 73,364,000 9,333,000 (80,091,000) (107,546,000) 26,883,000 $ 111,316,000 (160,754,000)
Balance of shares outstanding, end of period (in shares) 147,369           147,369  
Balance, end of period $ 1,118,115,000 1,051,351,000 906,035,000 895,325,000 915,809,000 $ 931,210,000 $ 1,118,115,000 895,325,000
Foreign currency translation adjustment, tax $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Common stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance of shares outstanding, beginning of period (in shares) 147,363 148,810 150,794 152,546 155,160 157,586 150,794 157,586
Balance, beginning of period $ 590,000 $ 596,000 $ 604,000 $ 610,000 $ 621,000 $ 630,000 $ 604,000 $ 630,000
Purchase and retirement of common stock (in shares)   (1,489) (2,181) (1,895) (2,661) (2,607)    
Purchase and retirement of common stock   $ (6,000) $ (9,000) $ (7,000) $ (11,000) $ (10,000)    
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding (in shares) 6 42 197 34 47 181    
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding     $ 1,000     $ 1,000    
Balance of shares outstanding, end of period (in shares) 147,369 147,363 148,810 150,685 152,546 155,160 147,369 150,685
Balance, end of period $ 590,000 $ 590,000 $ 596,000 $ 603,000 $ 610,000 $ 621,000 $ 590,000 $ 603,000
Additional paid-in capital                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period 1,106,926,000 1,114,504,000 1,129,511,000 1,142,081,000 1,160,865,000 1,179,721,000 1,129,511,000 1,179,721,000
Non-cash share-based compensation 3,765,000 3,481,000 2,463,000 2,781,000 2,887,000 1,409,000    
Purchase and retirement of common stock   (11,153,000) (16,339,000) (14,190,000) (21,781,000) (19,512,000)    
Exercise of stock options and vesting of restricted stock units, net of shares withheld to satisfy tax withholding   86,000 (1,129,000) 80,000 91,000 (774,000)    
Change in noncontrolling interests 321,000              
Equitable adjustments to stock-based awards 1,000 8,000 (2,000) (3,000) 19,000 21,000    
Balance, end of period 1,111,013,000 1,106,926,000 1,114,504,000 1,130,749,000 1,142,081,000 1,160,865,000 1,111,013,000 1,130,749,000
Retained earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period 323,466,000 246,273,000 291,644,000 128,130,000 17,411,000 41,862,000 291,644,000 41,862,000
Purchase and retirement of common stock   (17,890,000) (25,875,000) (14,381,000) (17,411,000) (13,700,000)    
Net income (loss) 34,487,000 95,083,000 (19,496,000) 85,463,000 128,130,000 (10,751,000)    
Balance, end of period 357,953,000 323,466,000 246,273,000 199,212,000 128,130,000 17,411,000 357,953,000 199,212,000
Accumulated other comprehensive loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period (379,510,000) (452,874,000) (462,210,000) (352,807,000) (245,261,000) (272,144,000) (462,210,000) (272,144,000)
Foreign currency translation adjustment, net of tax of $0 28,620,000 73,364,000 9,336,000 (80,091,000) (107,546,000) 26,883,000    
Balance, end of period (350,890,000) (379,510,000) (452,874,000) (432,898,000) (352,807,000) (245,261,000) (350,890,000) (432,898,000)
Non-controlling interests                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Balance, beginning of period (121,000) (2,464,000) (2,404,000) (2,205,000) (2,426,000) (2,329,000) (2,404,000) (2,329,000)
Change in noncontrolling interests (321,000)              
Net income (loss) (108,000) 2,343,000 (57,000) (136,000) 221,000 (97,000)    
Foreign currency translation adjustment, net of tax of $0 (1,000)   (3,000)          
Balance, end of period $ (551,000) $ (121,000) $ (2,464,000) $ (2,341,000) $ (2,205,000) $ (2,426,000) $ (551,000) $ (2,341,000)